Processed amnion/chorion allograft and Excellion-processed amnion allograft characterization and trial design aligned with AHRQ standards for chronic lower extremity ulcers
International Journal of Tissue Repair · 2026
DOI: 10.63676/km40xx10 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Tissue Repair, 2026. Verfasst von Matthew Davis und 2 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Aims
This study protocol is designed to evaluate whether Excellion-processed amnion/chorion allograft (EPACA) and amniotic allograft (EPAA) accelerate closure and improve quality of life compared with standard of care (SOC) for chronic diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs), respectively.
Methods
This randomized, controlled, multicenter trial enrolls adults with DFUs (>1–25 cm²) or VLUs (>1–50 cm²) unresponsive to SOC after a 2-week run-in (
Zitieren
APA
Davis, M., McKeown, P., & Michaelson, J. (2026). Processed amnion/chorion allograft and Excellion-processed amnion allograft characterization and trial design aligned with AHRQ standards for chronic lower extremity ulcers. International Journal of Tissue Repair. https://doi.org/10.63676/km40xx10
Vancouver
Davis M, McKeown P, Michaelson J. Processed amnion/chorion allograft and Excellion-processed amnion allograft characterization and trial design aligned with AHRQ standards for chronic lower extremity ulcers. International Journal of Tissue Repair. 2026. doi:10.63676/km40xx10
BibTeX
@article{Davis2026,
author = {Davis, Matthew and McKeown, Pamela and Michaelson, Jacob},
title = {Processed amnion/chorion allograft and Excellion-processed amnion allograft characterization and trial design aligned with AHRQ standards for chronic lower extremity ulcers},
journal = {International Journal of Tissue Repair},
year = {2026},
doi = {10.63676/km40xx10}
}
EUVIMED